Cargando…
Developing Photoaffinity Probes for Dopamine Receptor D(2) to Determine Targets of Parkinson’s Disease Drugs
[Image: see text] Dopaminergic pathways control highly consequential aspects of physiology and behavior. One of the most therapeutically important and best-studied receptors in these pathways is dopamine receptor D(2) (DRD2). Unfortunately, DRD2 is challenging to study with traditional molecular bio...
Autores principales: | Kim, Spencer T., Doukmak, Emma J., Flax, Raymond G., Gray, Dylan J., Zirimu, Victoria N., de Jong, Ebbing, Steinhardt, Rachel C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585581/ https://www.ncbi.nlm.nih.gov/pubmed/36183275 http://dx.doi.org/10.1021/acschemneuro.2c00544 |
Ejemplares similares
-
Photoactivatable
Agonist–Antagonist Pair as
a Tool for Precise Spatiotemporal Control of Serotonin Receptor 2C
Signaling
por: Kim, Spencer T., et al.
Publicado: (2023) -
Recent Advances in Target Characterization and Identification by Photoaffinity Probes
por: Sumranjit, Jitapa, et al.
Publicado: (2013) -
Photo-Brook rearrangement of acyl silanes as a strategy for photoaffinity probe design
por: Page, Annika C. S., et al.
Publicado: (2022) -
Olaparib‐Based Photoaffinity Probes for PARP‐1 Detection in Living Cells
por: Voorneveld, Jim, et al.
Publicado: (2020) -
Synthesis of Arylazide‐ and Diazirine‐Containing CrAsH‐EDT(2) Photoaffinity Probes
por: Syeda, Shameem S., et al.
Publicado: (2016)